February 20, 2012 — The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.
"Building on more than 60 years of stereotaxy experience, Fraxion provides the accuracy and precision that clinicians need for even the most challenging cranial SRT cases," says Dee Mathieson, senior vice president, oncology business line management, Elekta. "Coupled with Elekta's state-of-the-art Monaco treatment planning and an unequalled specification for high resolution beam shaping with Apex, Elekta's latest multileaf collimator, these solutions provide our clinical users with a simple, efficient way to expand their practice into stereotaxy."
Clinicians at Royal Preston Hospital's Rosemere Cancer Centre in Preston, United Kingdom, were impressed by the head frame's ease of use, accuracy and patient comfort.
"Fraxion integrates well into our Elekta environment," says Glyn Shentall, head of radiotherapy physics at the Royal Preston Hospital. "The head frame is a non-invasive, well-tolerated system that provides high intra-fraction immobilization accuracy. Patient setup for treatment is straightforward and radiographer confidence in the system is high."
Fraxion head fixation can be used for virtually any patient. The patient can be immobilized with a thermoplastic mask, with the vacuum mouthpiece, or even a combination of both systems. Precise repositioning is possible as the system is directly connected to the treatment table and micro adjustments are possible via easily accessible screws for full 6-D patient positioning.
The partial and full head thermoplastic masks provide alternative immobilization options for non-invasive setup, without compromising accuracy. Combining the thermoplastic mask with the vacuum mouthpiece increases flexibility in setup options, allowing optimal setup based on the patient's needs.
For more information: www.elekta.com
April 25, 2024 
